← Back to Search

Vein Entry Indicator Device

SU-VEID™ for Intravenous Access in Children

N/A

Waitlist Available

Led By Michael Nemergut, MD, PhD

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline

Awards & highlights

Study Summary

This trial will compare the success rates of two different methods for starting an IV in children.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

IV Start first-attempt success rate

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SU-VEID assisted IV InsertionExperimental Treatment1 Intervention

Pediatric patients in surgical pre-op requiring an IV catheter for surgery will have IV insertion using SU-VEID device

Group II: Standard IV InsertionActive Control1 Intervention

Pediatric patients in surgical pre-op requiring an IV catheter for surgery will have standard IV insertion

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,205 Previous Clinical Trials

3,766,384 Total Patients Enrolled

1 Trials studying Intravenous Access

20 Patients Enrolled for Intravenous Access

Michael Nemergut, MD, PhDPrincipal InvestigatorMayo Clinic

Media Library

SU-VEID™ (Vein Entry Indicator Device) Clinical Trial Eligibility Overview. Trial Name: NCT05204082 — N/A

Intravenous Access Research Study Groups: SU-VEID assisted IV Insertion, Standard IV Insertion

Intravenous Access Clinical Trial 2023: SU-VEID™ Highlights & Side Effects. Trial Name: NCT05204082 — N/A

SU-VEID™ (Vein Entry Indicator Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05204082 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any recruitment opportunities for this experiment?

"According to the information displayed on clinicaltrials.gov, this study is no longer actively recruiting patients. It was first posted in late March of 2022 and edited most recently at the start of April that same year. However, there are other trials open for recruitment currently taking place as well."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children

Michael E. Nemergut 2022. "A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05204082.